Matching the price of your asset to the value it brings to patients, healthcare systems and wider society.
Our pricing solutions help you achieve a price for your health technology which reflects its true value to patients, different healthcare systems and society as a whole.
What we do
Inbeeo can help you address a wide range of complex factors to advocate for prices based on objective evidence and insights so you can realize a price based on your asset’s true value. We will help you:
Perform agile portfolio evaluations, comparing assets across your portfolio based on their potential for pricing and market access success
Develop different clinical and HTA scenarios impacting the probability of achieving your asset’s target price
Establish an economically justifiable price range in early development, which becomes more precise as more data becomes available
Inform your price and launch sequence, at asset and new indication launch
Define your gross-to-net pricing policy across geographies
How we do it
We support you to “price right”, with a suite of proprietary tools designed to demonstrate the full value of your assets. We work with you to identify and quantify key value drivers, then turn them into intuitive value metrics.
Our research and intelligence generate all the data and evidence you need to support your pricing arguments, by:
Gathering secondary pricing insights regarding the unmet need, value drivers and willingness to pay
Conducting qualitative and quantitative pricing research
Developing business cases
Planning based on different scenarios
Understanding the constraints faced by payers, and how to minimize or overcome potential pricing challenges and access barriers
The tools we use
Our proprietary custom value assessment framework, based on Multiple-Criteria Decision Analysis (MCDA) techniques to compare value and price levels with comparable and competitor products.
Our Payer and KOL council network of more than 100 international experts based around the world, to leverage for qualitative and quantitative pricing research.
